Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 5, 2003
Promoting safer sex among HIV-positive youth with haemophilia: theory, intervention, and outcome
R B Butler, J R Schultz, A D Forsberg, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 3, 2011
The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience
M Kurth, J Puetz, P Kouides, et al.
Thrombosis and Haemostasis
|
September 1, 1995
Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH
C K Kasper, D L Aronson, G Davignon, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
October 1, 1991
Internal carotid flow velocity with exercise before and after acclimatization to 4,300 m
S Y Huang, K W Tawney, P R Bender, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 29, 2009
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII
M Recht, L Nemes, M Matysiak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 30, 2009
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project
R Kulkarni, J M Soucie, J Lusher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 14, 2007
The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium
B M Feldman, L Aledort, M Bullinger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 28, 2011
Joint health and functional ability in children with haemophilia who receive intensive replacement therapy
W Groen, J van der Net, K Bos, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 5, 2016
Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System
R Kulkarni, R J Presley, J M Lusher, et al.
Journal of Thrombosis and Thrombolysis
|
November 18, 2006
The U.S. Thrombosis and Hemostasis Centers pilot sites program
N F Dowling, M G Beckman, M Manco-Johnson, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 5, 2003
Promoting safer sex among HIV-positive youth with haemophilia: theory, intervention, and outcome
R B Butler, J R Schultz, A D Forsberg, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 3, 2011
The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience
M Kurth, J Puetz, P Kouides, et al.
Thrombosis and Haemostasis
|
September 1, 1995
Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH
C K Kasper, D L Aronson, G Davignon, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
October 1, 1991
Internal carotid flow velocity with exercise before and after acclimatization to 4,300 m
S Y Huang, K W Tawney, P R Bender, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 29, 2009
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII
M Recht, L Nemes, M Matysiak, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 30, 2009
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project
R Kulkarni, J M Soucie, J Lusher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 14, 2007
The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium
B M Feldman, L Aledort, M Bullinger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 28, 2011
Joint health and functional ability in children with haemophilia who receive intensive replacement therapy
W Groen, J van der Net, K Bos, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 5, 2016
Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System
R Kulkarni, R J Presley, J M Lusher, et al.
Journal of Thrombosis and Thrombolysis
|
November 18, 2006
The U.S. Thrombosis and Hemostasis Centers pilot sites program
N F Dowling, M G Beckman, M Manco-Johnson, et al.
Page
of 6